EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

90 hedge funds and large institutions have $196M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
-4
Holders Change %
-4.26%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
35
Reduced
26
Closed
13
Calls
$4.08M
Puts
$803K
Net Calls
+$3.28M
Net Calls Change
+$958K

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$47M
2
6CM
2
683 Capital Management
New York
$25.1M
3
BCM
3
Bridgeway Capital Management
Texas
$1.1M
4
Morgan Stanley
4
Morgan Stanley
New York
$985K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$14.4M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$1.5M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$290K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AIC
101
Ameritas Investment Company
Nebraska
– -$3.39K -13 Closed
SFS
102
Sowell Financial Services
Arkansas
– -$1K -3 Closed
1 2 3 4
5